Verve Therapeutics (VERV) Shares Gain Ground In Pre-Hour Session
After a major regulatory development, Verve Therapeutics, Inc. (NASDAQ: VERV) shares enjoyed a notable surge. The news that the U.S. Food and Drug Administration (FDA) had given VERVE-102 Fast Track designation caused VERV stock to rise 8.52% to $3.31 as of the last check during pre-market trading. Breakthrough Therapy Addresses an Ongoing Issue By lowering …
Verve Therapeutics (VERV) Shares Gain Ground In Pre-Hour Session Read More »